Implementation of a liver health check in people with type 2 diabetes-Reference-Cited by-同舟云学术

Implementation of a liver health check in people with type 2 diabetes

Published:2024-01 Issue:1 Volume:9 Page:83-91
ISSN:2468-1253
Container-title:The Lancet Gastroenterology & Hepatology
language:en
Short-container-title:The Lancet Gastroenterology & Hepatology

Author:

Abeysekera Kushala W M,Valenti Luca,Younossi Zobair,Dillon John F,Allen Alina M^ORCID,Nourredin Mazen,Rinella Mary E,Tacke Frank,Francque Sven^ORCID,Ginès Pere,Thiele Maja^ORCID,Newsome Philip N,Guha Indra Neil,Eslam Mohammed,Schattenberg Jörn M^ORCID,Alqahtani Saleh A,Arrese Marco^ORCID,Berzigotti Annalisa^ORCID,Holleboom Adriaan G,Caussy Cyrielle^ORCID,Cusi Kenneth,Roden Michael^ORCID,Hagström Hannes,Wong Vincent Wai-Sun,Mallet Vincent,Castera Laurent,Lazarus Jeffrey V^ORCID,Tsochatzis Emmanuel A^ORCID

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference81 articles.

1. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review;Younossi;Hepatology,2023

2. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017;Lancet Gastroenterol Hepatol,2020

3. NAFLD and alcohol-associated liver disease will be responsible for almost all new diagnoses of cirrhosis in Canada by 2040;Flemming;Hepatology,2021

4. Prospective study of outcomes in adults with nonalcoholic fatty liver disease;Sanyal;N Engl J Med,2021

5. NASH leading cause of liver transplant in women: updated analysis of indications for liver transplant and ethnic and gender variances;Noureddin;Am J Gastroenterol,2018

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diabetes as a risk factor for MASH progression;Diabetes Research and Clinical Practice;2024-11

2. Intervening on Metabolic Dysfunction-Associated Steatotic Liver Disease in Latino/a and Black Patients with Diabetes: A Feasibility Pilot;Diabetes Therapy;2024-09-14

3. EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD);Journal of Hepatology;2024-09

4. Population screening for cirrhosis;Hepatology Communications;2024-08-26

5. Automated Fibrosis-4 Index: Simplifying Non-Alcoholic Fatty Liver Disease for Diabetologists;Medicina;2024-08-08